African Medical Centre of Excellence (AMCE) Opens its Doors to the Public as it Seeks to Transform Healthcare in Africa
Located in Abuja and designed to meet the highest global standards, AMCE Abuja offers world-class services across oncology, haematology, cardiology, and general medical services. More than a hospital, the facility represents a bold statement of Africa's determination to reduce dependence on foreign health systems and reverse the estimated US$6-10 billion Africans spend annually seeking treatment abroad.
The opening of AMCE Abuja comes at a critical time, as Africa seeks to strengthen its healthcare systems and reduce reliance on external providers. The COVID-19 pandemic exposed the vulnerabilities of this reliance, with global supply shortages putting immense pressure on African nations. Similarly, past responses to health crises like Ebola have reinforced the urgent need for resilient, homegrown solutions. Decades after independence, millions of Africans continue to suffer from diseases like sickle cell and malaria, conditions that could be better managed with targeted local research and investment. Yet these illnesses often receive limited global attention or funding, leaving critical treatment gaps. AMCE Abuja represents a bold step forward, bringing world-class care to the continent, centering African health priorities, and laying the groundwork for a healthier, more self-reliant future. In strategic partnership with Bank of Industry (BOI), and Nigerian National Petroleum Corporation Limited (NNPCL), AMCE reflects what's possible when African institutions unite with shared purpose.
'Today, we are not merely unveiling a building, we are making a bold, collective statement: we will no longer accept medical vulnerability as destiny. The African Medical Centre of Excellence stands as proof that Africa is ready to compete with the best in global healthcare. I commend Afreximbank and its visionary President, Professor Benedict Oramah, and salute the partnership with King's College Hospital for turning this audacious dream into reality. This is what happens when African institutions confront African challenges with African solutions.
'Over the past two years, we have taken deliberate steps to transform Nigeria's health sector—from unlocking the healthcare value chain through the Presidential Initiative (PVAC), to expanding pharmaceutical production, regulatory systems, and diagnostic access, and securing over $2.2 billion in new investments through the Nigeria Health Sector Renewal Initiative. But excellence must be sustained. That's why we're investing in the roads, power, and connectivity that enable great institutions to thrive. With the largest stem cell lab in West Africa and plans for a medical school, this Centre is more than a hospital, it is a place to heal the sick, and to train the future.' — H.E. Bola Ahmed Tinubu, GCFR, President and Commander-in-Chief of the Armed Forces, Federal Republic of Nigeria, represented by H.E. Senator Kashim Shettima, Vice President of the Federal Republic of Nigeria
Commenting on the momentous achievement, Prof. Benedict Oramah, President and Chairman of the Board of Directors of both Afreximbank and AMCE, thanked the Federal Government of Nigeria for providing the land on which the AMCE stands, adding: " In 2013, I had my own close call when I became seriously ill and was evacuated to King's College Hospital in London, where a frantic battle to save my life ensued. Being here today is a testament to the power of cutting-edge medical research, clinical knowledge, and a solid healthcare ecosystem. The event we mark today is proof that society is better off saving lives than burying its dead, and that it is a living person who can contribute to development and social transformation. This experience led me to conclude that one of the major contributions I could make to Africa was to help Afreximbank deliver on its health and medical strategy in every way possible. Our vision for the African Medical Centre of Excellence is not just to provide top-notch healthcare but to serve as a catalyst for the transformation of the African health sector, making a bold statement to the world that Africa is finally taking its destiny into its own hands in healthcare sovereignty and global standards."
President Oramah also announced the launch of the Africa Life Sciences Foundation to act as the vehicle for mobilising appropriate risk capital to drive research efforts and called on African and non-African governments, banks, high net worth individuals and corporate organisations to join the Bank in investing in the hospital, through this platform.
Brian Deaver, Chief Executive Officer of AMCE, highlighted the facility's comprehensive approach: "Today, we don't just open a hospital—we launch a healthcare revolution for Africa. AMCE represents a paradigm shift in how specialised medical care is delivered on the continent. Our integrated model encompasses early diagnosis, advanced treatment, and long-term disease management, creating a seamless continuum of care that improves patient outcomes and health experiences."
He added: "Our mission extends beyond treatment to include world-class medical education, groundbreaking research, and continuous innovation. By combining international expertise with local talent development, AMCE will build sustainable healthcare capacity that serves generations to come.
AMCE's opening signals a new era for Africa — one in which self-reliance replaces dependency, and world-class care is no longer the privilege of a few but the standard for many. By anchoring healthcare delivery, talent development, and innovation on the continent, AMCE is not just stemming the outflow of medical dollars, but redefining Africa's place in the global health ecosystem.
Through its clinical partnerships with King's College Hospital, London and The Christie NHS Foundation Trust, AMCE will be home to advance research, education, and medical excellence by fostering continuous knowledge exchange. In its next phase, AMCE will expand to include a second 350-bed hospital, medical and nursing schools, a medical sciences foundation, research centres, and residential facilities. Together, this integrated ecosystem will position Nigeria as a leading hub for specialist healthcare, medical training, and clinical research on the continent.
Professor Clive Kay, Chief Executive Officer of King's College Hospital NHS Foundation Trust said, "We are proud to partner with Afreximbank on this important initiative. The African Medical Centre of Excellence represents a positive step forward, and by bringing together world-class clinical standards, training, and research, we aim to share our expertise and support the development of a sustainable model of care that responds directly to the needs of African patients'.
Now open, AMCE welcomes patients, healthcare professionals, researchers, and partners to join its mission of delivering world-class healthcare, fostering innovation, and building a healthier, more self-reliant Africa. AMCE is the largest specialised private hospital in Nigeria and West Africa focusing on cardiovascular services, haematology, comprehensive oncology, and general medical services. It currently boasts of 170 beds with a plan to expand this to 500 beds upon completion. It features the largest stem cell laboratory in the region, fifteen post stem cell isolation rooms in West Africa alongside five theatres and three catheterisation laboratories. It also features a 20 bed intensive care unit, six critical care unit beds and 20 chemotherapy chairs with compounding pharmacy among others. Some of the specialised equipment in Nigeria and the region are exclusively hosted by AMCE Abuja. They include the 18 Mev cyclotron, 3 Tesla Magnetic Resonance Imaging, 256 slices computed tomography, brachytherapy machine with iridium source, 4 biosafety cabinets and 128 slices computed tomography machines, among others.
Distributed by APO Group on behalf of Afreximbank.
Media Contact:
Vincent Musumba
Communications and Events Manager (Media Relations)
Email: press@afreximbank.com
Follow us on:
X: https://apo-opa.co/3HtU0hp
Facebook: https://apo-opa.co/43zs1FS
LinkedIn: https://apo-opa.co/3HuDJcg
Instagram: https://apo-opa.co/43vr6Gl
About the African Medical Centre of Excellence (AMCE) Abuja:
The African Medical Centre of Excellence (AMCE) Abuja is a tertiary-level multi-specialty medical institution developed by Afreximbank in collaboration with King's College Hospital, London. It is setting new standards in specialty healthcare and patient experience across Africa. Established to address critical gaps, AMCE Abuja is dedicated to providing world-class care through innovative research, development, and education.
The AMCE Abuja will deliver comprehensive services in oncology, haematology, cardiovascular care, and general healthcare, with plans for future expansion. Its primary goal is to reduce medical tourism by offering advanced procedures, such as stem cell transplantation, and state-of-the-art treatments for various diseases. The construction phase, supported by global partners, will be followed by a phased rollout over six years, culminating in a 500-bed facility. By tackling healthcare brain drain and reducing medical tourism, AMCE Abuja will create employment opportunities across both medical and non-medical sectors. Following the groundbreaking ceremony in December 2021 by former President Muhammadu Buhari, AMCE Abuja is scheduled to commence operations in early 2025. This flagship facility is a crucial component of Afreximbank's network of healthcare facilities, aiming to address brain drain, decrease medical tourism, and foster job creation. The vision for AMCE is to shape a healthier and more educated future for Africa.
About Afreximbank:
African Export-Import Bank (Afreximbank) is a Pan-African multilateral financial institution mandated to finance and promote intra- and extra-African trade. For over 30 years, the Bank has been deploying innovative structures to deliver financing solutions that support the transformation of the structure of Africa's trade, accelerating industrialisation and intra-regional trade, thereby boosting economic expansion in Africa. A stalwart supporter of the African Continental Free Trade Agreement (AfCFTA), Afreximbank has launched a Pan-African Payment and Settlement System (PAPSS) that was adopted by the African Union (AU) as the payment and settlement platform to underpin the implementation of the AfCFTA. Working with the AfCFTA Secretariat and the AU, the Bank has set up a US$10 billion Adjustment Fund to support countries effectively participating in the AfCFTA. At the end of December 2024, Afreximbank's total assets and contingencies stood at over US$40.1 billion, and its shareholder funds amounted to US$7.2 billion. Afreximbank has investment grade ratings assigned by GCR (international scale) (A), Moody's (Baa1), China Chengxin International Credit Rating Co., Ltd (CCXI) (AAA), Japan Credit Rating Agency (JCR) (A-) and Fitch (BBB-). Afreximbank has evolved into a group entity comprising the Bank, its equity impact fund subsidiary called the Fund for Export Development Africa (FEDA), and its insurance management subsidiary, AfrexInsure (together, "the Group"). The Bank is headquartered in Cairo, Egypt.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The National
12 hours ago
- The National
Abu Dhabi anti-smoking programmes do not only save lives - they also save fortunes, study suggests
Programmes helping people to quit smoking in Abu Dhabi can save billions of dirhams that would otherwise be lost because of treatment costs and reduced productivity, a study has found. The amounts that they save are more than 16 times as much as the cost of the schemes, the analysis by researchers at UAE University has shown. The large-scale savings suggested in the study come even when the smoking cessation measures are assumed to help just 7.5 per cent of people, or fewer than one in 13, to quit. 'This economic analysis presents robust evidence indicating that the return on investment ratio associated with smoking cessation programmes in Abu Dhabi is considerably favourable,' the researchers wrote. The study estimated the total savings from the prevention of cases of asthma, cerebrovascular disease (conditions that affect blood flow to the brain and can result in strokes), chronic obstructive pulmonary disease (COPD), heart disease, lower respiratory infections and lung and other cancers. The authors, based at UAE University, Abu Dhabi Public Health Centre and The Golden Helix Foundation, a London-based charity that supports medical research, calculated the potential annual savings per condition that result from smoking cessation programmes, and multiplied this by the expected lifespan of the patient. Looking at programmes being provided to a 'target population' of 268,869 smokers in Abu Dhabi, it calculated that if Dh539.7 million is spent on quitting programmes, the savings, added over the lifetime of the patients involved, will be Dh8.89 billion, resulting in a net benefit of Dh8.35 billion. This represents a return on investment – the ratio of the benefit gained compared to the amount spent – of 16.48. A report last year showed there was urgent need to reduce smoking levels in the region. Data published last year by the World Health Organisation forecasts tobacco-related deaths to increase over the coming decades, including cases of lung and oral cancer, lung condition COPD, heart disease and strokes, unless action is taken. The study looked at the impact of smoking across seven nations – Pakistan, Egypt, Lebanon, Jordan, Kuwait, Saudi Arabia and the UAE. Of the 390 million people living in the region, about 61 million adults use tobacco. About 384,000 die prematurely each year as a result. Bigger picture Dr Bassam Mahboub, a pulmonologist and head of the Emirates Respiratory and Allergy Society, who was not connected to the study, said that smoking cessation programmes offered short and long-term health benefits. 'In the short term it will prevent the asthma attacks, the COPD attacks and it will reduce the cost on the patient,' he said. 'In the long term it will prevent the complications from smoking, which is all the cardiovascular diseases, metabolic diseases like diabetes and hyperlipidaemia and the cardiovascular risk and finally all kinds of cancers from mouth cancers all the way to respiratory cancers and lung cancers.' Dr Mahboub told The National that in the previous week alone he had seen three young people who had been keen to stop smoking. 'First and the most important intervention is the willingness,' he said. 'Then you have to replace the nicotine. Then after that you can talk about something else like antidepressants.' He said that with older patients, doctors often highlight the risk of cardiac disease and cancers, while with younger patients, messaging centres on issues such as the smell caused by smoking, mouth infections, coughing and limitations on exercise. One factor that may limit investments in smoking cessation schemes is, the study authors suggest, the fact that the monetary savings they result in are not immediate. Long-term investment 'While the financial and public health benefits, such as reduced healthcare expenditures and increased productivity, will accrue gradually over time, the initial investment in cessation initiatives requires immediate allocation of resources,' they wrote. 'This discrepancy presents a policy challenge, as decision-makers must navigate short-term fiscal constraints while ensuring long-term societal gains.' Dr Rachel Kaminski, a pulmonologist who has helped established a smoking cessation programme at Saudi German Hospital in Dubai, said that the study highlighted the cost-effectiveness of smoking cessation. There is, she said, 'a massive unmet need' with smoking cessation, treatments and clinics. She said that patients who came off cigarettes or vapes did not just see improvements in their respiratory or cardiovascular health, but in their general health, with fewer work days missed and lower mortality. 'I know myself that if I've managed to get my patients with severe chronic obstructive pulmonary disease or asthma to stop smoking, their outcomes instantly improve,' she said. At the smoking cessation clinics Dr Kaminski is involved with, patients receive nicotine replacement treatment, cognitive behavioural therapy and support therapy. 'We know that our patients with chronic diseases, cardiovascular diabetes and respiratory diseases benefit the most from this,' she said. Dr Mohammed Harriss, a consultant pulmonologist at Medcare Royal Speciality Hospital in Dubai, said that the study suggested that smoking-cessation programmes in Abu Dhabi 'generate significantly more financial savings than their costs'. He said that when patients stopped smoking, they often have fewer flare-ups and hospital visits, reducing the pressure on resources. 'Seeing the financial benefits alongside the health improvements makes a strong case for giving smoking cessation a higher priority within pulmonology services,' he said. A combination of medication to manage cravings, and behavioural support, which helps patients change habits, s most effective, according to Dr Harriss. 'This approach isn't difficult to scale in a hospital setting especially when brief advice, referral pathways, and trained staff are built into routine care. Even small interventions during appointments can go a long way,' he said. Digital platforms and telehealth can support patients outside the hospital, Dr Harriss said, making reminders and follow-up easier and helping patients to stay on track.
Zawya
a day ago
- Zawya
Oman: MoH-OMIFCO sign agreement to provide home ventilators for low-income patients
Muscat – The Ministry of Health today signed a financing agreement with the Oman India Fertilizer Company (OMIFCO) to purchase ventilators for low-income and social security patients for the sixth consecutive time. The agreement was signed on behalf of the Ministry of Health by Saud bin Amer al Nazairi, Director General of Financial Affairs, and on behalf of the Oman India Fertilizer Company (OMIFCO) by Khalid bin Mohammed al Fannah al Arimi, Director of Sustainability and Corporate Communications. Saud bin Amer al Nazairi emphasised the importance of partnerships between the government sector and other sectors in the Sultanate of Oman to serve the public interest, praising the company's generous initiative to finance the purchase of home respirators for low-income and social security groups for the sixth consecutive time. He added that the agreement aims to reduce patients' hospital stays, reduce the economic cost to the Ministry of Health, reduce patients' exposure to hospital-acquired infections due to their longer stays, allow for the hospitalisation of other patients, and reduce social pressure on the patient's family. He pointed out that the draft agreement stems from a strategic partnership to achieve the public good of society and advance community services and development projects of public benefit. Home ventilators play a vital role in improving the quality of life for patients with chronic or acute respiratory problems. Their importance is especially important for those who require continuous or long-term respiratory support outside the hospital, as they support breathing in certain chronic conditions such as chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, respiratory muscle weakness, and sleep apnea. These devices help reduce the need for hospitalisation, improve the quality of life for patients who need them, and enable better monitoring and control of their health. They are an essential part of some home care programs and provide a safe and sustainable option for some patients who require long-term mechanical ventilation outside the hospital. Home ventilators are not just a medical aid; they are an essential component of many patients' lives, providing them with safety, comfort, and independence, and are a cost-effective option compared to prolonged hospital care. © Apex Press and Publishing Provided by SyndiGate Media Inc. (
Zawya
a day ago
- Zawya
Berkshire invests in UnitedHealth, trims Apple stake
Warren Buffett's Berkshire Hathaway disclosed on Thursday a new investment in UnitedHealth Group after the insurer became a target for many Americans upset over the direction of the nation's healthcare. Berkshire said it owned 5.04 million UnitedHealth shares worth about $1.57 billion as of June 30. The disclosure came in a U.S. Securities and Exchange Commission filing detailing Berkshire's U.S.-listed common stock holdings as of June 30. UnitedHealth shares soared 8.5% in after-hours trading. Buffett's conglomerate also said it sold 20 million shares of iPhone maker Apple in the second quarter, reducing its largest stock holding to 280 million shares, and cut back another major holding, Bank of America. Berkshire also boosted its bet on home builders, revealing a new stake in DR Horton and significantly larger stake in Lennar. The filing also disclosed new Berkshire investments in security products provider Allegion, outdoor advertiser Lamar Advertising and steel maker Nucor It is not clear whether Buffett, his portfolio managers Todd Combs and Ted Weschler, or future Chief Executive Greg Abel are behind individual purchases and sales. But stock prices often rise when Berkshire makes purchases because investors view them as a seal of approval from Buffett. DR Horton, Lennar, Allegion, Lamar and Nucor also rose in after-hours trading. TAPEWORM Shares of UnitedHealth, part of the Dow Jones industrial average, had through Thursday fallen 46% this year amid rising costs, a U.S. Department of Justice probe related to its billing practices, a cyberattack, and the shooting death of former top executive Brian Thompson last December. Buffett has called high health care costs a "tapeworm" that limits economic growth, and with JPMorgan Chase's Jamie Dimon and Jeff Bezos tried unsuccessfully to improve healthcare for their companies' employees. Their joint venture, Haven, shut down after three years in 2021. UnitedHealth did not immediately respond to requests for comment on Berkshire's investment. The Apple sales, Berkshire's first since the third quarter of 2024, further reduced what was once a 905 million share stake, but do not signal a full-blown retreat from the stock. Apple shares were little changed after hours. Despite the new purchases, Berkshire sold $3 billion more stocks than it bought between April and June, the 11th straight quarter it was a net seller of stocks. It ended June with $344.1 billion of cash and equivalents. Other changes in Thursday's filing included larger stakes in oil company Chevron, alcoholic beverages maker Constellation Brands and Domino's Pizza, and exiting a stake in wireless network operator T-Mobile. Berkshire also revealed it had been buying DR Horton, Lennar and Nucor stock before April, but the SEC let it keep the purchases confidential so investors would not try to piggyback. Based in Omaha, Nebraska, Berkshire also owns close to 200 businesses including Geico car insurance, the BNSF railroad, and many energy, industrial, retail and service companies. Buffett turns 95 on August 30. He is expected to remain Berkshire's chairman after Abel, 63, becomes chief executive on January 1, 2026. (Reporting by Jonathan Stempel in New York; Additional reporting by Christy Santhosh in Bengaluru; Editing by Richard Chang and Stephen Coates)
